IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i7p4400-d788067.html
   My bibliography  Save this article

The Impact of Two-Invoice System on Pharmaceutical Manufacturers’ Selling Expenses in China: A Difference-in-Differences Approach

Author

Listed:
  • Yi Ran

    (School of Economics and Management, Tongji University, Shanghai 200092, China
    SPH KDL Health Chongqing Pharmaceutical Co., Ltd., Chongqing 400050, China)

  • Yuanyuan Hu

    (School of Economics and Management, Tongji University, Shanghai 200092, China)

  • Shouming Chen

    (School of Economics and Management, Tongji University, Shanghai 200092, China)

  • Fangjun Qiu

    (School of Economics and Management, Tongji University, Shanghai 200092, China)

  • Ahmed Rabeeu

    (School of Economics and Management, Tongji University, Shanghai 200092, China)

Abstract

A perennial question for the pharmaceutical industry has been excessive drug prices. To alleviate patients’ burden of expensive medical bills and increase the affordability of medicines, China adopted the Two-Invoice System (TIS) in drug procurement for public medical institutions in 2017. In this paper, we study the impact of the TIS on pharmaceutical manufacturers’ selling expenses. Using a Difference-in-Differences (DID) methodology and a sample of the A-share pharmaceutical manufacturing firms listed on the Shanghai Stock Exchange and Shenzhen Stock Exchange from the years 2014 to 2020, we find that the TIS leads to a significant increase in pharmaceutical manufacturers’ selling expenses but gradually weakens over time. In addition, we further explore whether the impact of the TIS on pharmaceutical manufacturers’ selling expenses is affected by the pharmaceutical manufacturers’ previous drug circulation mode. The results indicate that the TIS could significantly increase the pharmaceutical manufacturers’ selling expenses in the agency mode group. However, there is no evidence to support the TIS having the same effect in the direct sales office model group.

Suggested Citation

  • Yi Ran & Yuanyuan Hu & Shouming Chen & Fangjun Qiu & Ahmed Rabeeu, 2022. "The Impact of Two-Invoice System on Pharmaceutical Manufacturers’ Selling Expenses in China: A Difference-in-Differences Approach," IJERPH, MDPI, vol. 19(7), pages 1-18, April.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:7:p:4400-:d:788067
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/7/4400/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/7/4400/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Heyman, Fredrik & Sjoholm, Fredrik & Tingvall, Patrik Gustavsson, 2007. "Is there really a foreign ownership wage premium? Evidence from matched employer-employee data," Journal of International Economics, Elsevier, vol. 73(2), pages 355-376, November.
    2. Hongfeng Zhang & Lu Huang & Yan Zhu & Hongyun Si & Xu He, 2021. "Does Low-Carbon City Construction Improve Total Factor Productivity? Evidence from a Quasi-Natural Experiment in China," IJERPH, MDPI, vol. 18(22), pages 1-21, November.
    3. Caroline Flammer & Jiao Luo, 2017. "Corporate social responsibility as an employee governance tool: Evidence from a quasi-experiment," Strategic Management Journal, Wiley Blackwell, vol. 38(2), pages 163-183, February.
    4. Goodman-Bacon, Andrew & Marcus, Jan, 2020. "Using Difference-in-Differences to Identify Causal Effects of COVID-19 Policies," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 14(2), pages 153-158.
    5. Quan-Hoang Vuong & Tam-Tri Le & Viet-Phuong La & Huyen Thanh Thanh Nguyen & Manh-Toan Ho & Quy Khuc & Minh-Hoang Nguyen, 2022. "Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework," Palgrave Communications, Palgrave Macmillan, vol. 9(1), pages 1-12, December.
    6. Giulio Bottazzi & Angelo Secchi, 2005. "Growth and Diversification Patterns of the Worldwide Pharmaceutical Industry," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 26(2), pages 195-216, December.
    7. Kathryn Oliver & Annette Boaz, 2019. "Transforming evidence for policy and practice: creating space for new conversations," Palgrave Communications, Palgrave Macmillan, vol. 5(1), pages 1-10, December.
    8. Caroline Flammer & Aleksandra Kacperczyk, 2016. "The Impact of Stakeholder Orientation on Innovation: Evidence from a Natural Experiment," Management Science, INFORMS, vol. 62(7), pages 1982-2001, July.
    9. Sascha O. Becker & Andrea Ichino, 2002. "Estimation of average treatment effects based on propensity scores," Stata Journal, StataCorp LP, vol. 2(4), pages 358-377, November.
    10. Ruth Mayne & Duncan Green & Irene Guijt & Martin Walsh & Richard English & Paul Cairney, 2018. "Using evidence to influence policy: Oxfam’s experience," Palgrave Communications, Palgrave Macmillan, vol. 4(1), pages 1-10, December.
    11. Andrew Goodman-Bacon & Jan Marcus, 2020. "Difference-in-Differences to Identify Causal Effects of COVID-19 Policies," Discussion Papers of DIW Berlin 1870, DIW Berlin, German Institute for Economic Research.
    12. Yu, Xuan & Li, Cheng & Shi, Yuhua & Yu, Min, 2010. "Pharmaceutical supply chain in China: Current issues and implications for health system reform," Health Policy, Elsevier, vol. 97(1), pages 8-15, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mai, Nhat Chi, 2022. "The Impact of Two-Invoice System on Pharmaceutical Manufacturers’ Selling Expenses in China: A Difference-In-Differences Approach," OSF Preprints 68fsb, Center for Open Science.
    2. Wright, Austin L. & Sonin, Konstantin & Driscoll, Jesse & Wilson, Jarnickae, 2020. "Poverty and economic dislocation reduce compliance with COVID-19 shelter-in-place protocols," Journal of Economic Behavior & Organization, Elsevier, vol. 180(C), pages 544-554.
    3. Ilan Noy & Toshihiro Okubo & Eric Strobl, 2023. "The Japanese textile sector and the influenza pandemic of 1918–1920," Journal of Regional Science, Wiley Blackwell, vol. 63(5), pages 1192-1227, November.
    4. Kristin Hestmann Vinjerui & Ingeborg Hess Elgersma & Atle Fretheim, 2021. "Increased COVID-19 Testing Rates Following Combined Door-to-Door and Mobile Testing Facility Campaigns in Oslo, Norway, a Difference-in-Difference Analysis," IJERPH, MDPI, vol. 18(21), pages 1-11, October.
    5. Natalia Danzer & Mathias Huebener & Astrid Pape & C. Katharina Spieß & Nico A. Siegel & Gert G. Wagner, 2021. "Cracking under Pressure? Gender Role Attitudes toward Maternal Employment in Times of a Pandemic," Discussion Papers of DIW Berlin 1951, DIW Berlin, German Institute for Economic Research.
    6. Mathias Huebener & Sevrin Waights & C. Katharina Spiess & Nico A. Siegel & Gert G. Wagner, 2021. "Parental well-being in times of Covid-19 in Germany," Review of Economics of the Household, Springer, vol. 19(1), pages 91-122, March.
    7. Na Shen & Kevin Au & Weiwen Li, 2020. "Strategic alignment of intangible assets: The role of corporate social responsibility," Asia Pacific Journal of Management, Springer, vol. 37(4), pages 1119-1139, December.
    8. Bloem, Jeffrey R. & Salemi, Colette, 2021. "COVID-19 and conflict," World Development, Elsevier, vol. 140(C).
    9. Brodeur, Abel & Cook, Nikolai & Wright, Taylor, 2021. "On the effects of COVID-19 safer-at-home policies on social distancing, car crashes and pollution," Journal of Environmental Economics and Management, Elsevier, vol. 106(C).
    10. Heyman, Fredrik & Gustavsson Tingvall, Patrik & Sjöholm, Fredrik, 2006. "Acquisitions, Multinationals and Wage Dispersion," Working Paper Series 675, Research Institute of Industrial Economics.
    11. Kai Fischer & J. James Reade & W. Benedikt Schmal, 2021. "The Long Shadow of an Infection: COVID-19 and Performance at Work," Economics Discussion Papers em-dp2021-17, Department of Economics, University of Reading.
    12. Liu, Xianda & Hou, Wenxuan & Main, Brian G.M., 2022. "Anti-market sentiment and corporate social responsibility: Evidence from anti-Jewish pogroms," Journal of Corporate Finance, Elsevier, vol. 76(C).
    13. Alberto Bisin & Andrea Moro, 2020. "Learning Epidemiology by Doing: The Empirical Implications of a Spatial-SIR Model with Behavioral Responses," NBER Working Papers 27590, National Bureau of Economic Research, Inc.
    14. Alexander W. Bartik & Marianne Bertrand & Feng Lin & Jesse Rothstein & Matthew Unrath, 2020. "Measuring the Labor Market at the Onset of the COVID-19 Crisis," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 51(2 (Summer), pages 239-268;316.
    15. Edoardo Di Porto & Paolo Naticchioni & Vincenzo Scrutinio, 2020. "Partial Lockdown and the Spread of Covid-19: Lessons from the Italian Case," CSEF Working Papers 569, Centre for Studies in Economics and Finance (CSEF), University of Naples, Italy.
    16. Xianhai Huang & Hangyu Chen & Gaoju Yang, 2017. "Do Rising Labour Costs Drive Innovation in Enterprises? Propensity Score Matching Evidence from Chinese Firms," Pacific Economic Review, Wiley Blackwell, vol. 22(1), pages 23-42, February.
    17. Caroline Flammer & Ioannis Ioannou, 2021. "Strategic management during the financial crisis: How firms adjust their strategic investments in response to credit market disruptions," Strategic Management Journal, Wiley Blackwell, vol. 42(7), pages 1275-1298, July.
    18. Anna Godøy & Maja Weemes Grøtting, 2023. "Implementation and spillovers of local non‐pharmaceutical interventions," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 822-852, April.
    19. Beyer, Robert C.M. & Jain, Tarun & Sinha, Sonalika, 2023. "Lights out? COVID-19 containment policies and economic activity," Journal of Asian Economics, Elsevier, vol. 85(C).
    20. Nicola Borri & Francesco Drago & Chiara Santantonio & Francesco Sobbrio, 2021. "The “Great Lockdown”: Inactive workers and mortality by Covid‐19," Health Economics, John Wiley & Sons, Ltd., vol. 30(10), pages 2367-2382, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:7:p:4400-:d:788067. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.